UROLOGICAL SURVEY   ( Download pdf )

 

NEUROUROLOGY & FEMALE UROLOGY

Transurethral Radiofrequency Energy Collagen Micro-Remodeling For the Treatment of Female Stress Urinary Incontinence
Appell RA, Juma S, Wells WG, Lenihan JP, Klimberg IW, Kanellos A, Reilley SF
Department of Urology, Baylor College of Medicine, Houston, Texas, USA
Neurourol Urodyn. 2006; 25: 331-6

  • Aims: This prospective, randomized, controlled clinical trial was performed to demonstrate the 12 months safety and efficacy of transurethral radiofrequency energy (RF) collagen micro-remodeling in women with stress urinary incontinence (SUI).
  • Materials and Methods: Women with SUI, bladder outlet hypermobility, and leak point pressure (LPP) > or = 60 cmH(2)O were randomized to RF micro-remodeling or “sham treatment.” Adverse events (AEs) were recorded. Incidence of > or =10 point incontinence quality of life (I-QOL) score improvement, a magnitude of improvement with a demonstrated responsiveness to patient satisfaction with treatment and to > or =25% reduction in both incontinence episode frequency and stress pad weight, served as a subjective outcome measurement. Change in mean LPP served as an objective outcome measurement.
  • Results: 110 women underwent RF micro-remodeling and 63 underwent virtually identical “sham treatment” (with the exception of RF delivery). The 12 months RF micro-remodeling safety profile was statistically no different than that of sham treatment (a brief bladder catheterization). Seventy-four percent of women with moderate to severe baseline SUI experienced > or =10 point I-QOL score improvement at 12 months (P = 0.04). Women who underwent RF micro-remodeling demonstrated LPP elevation at 12 months, while sham treated women demonstrated LPP reduction (P = 0.02).
  • Conclusions: Non-surgical, transurethral RF micro-remodeling is a safe treatment for women with SUI. In women with moderate to severe SUI, this novel therapy resulted in statistically significant improvement in quality of life of a magnitude associated with patient satisfaction with the treatment. Women who underwent RF micro-remodeling demonstrated a statistically significant elevation in mean LPP at 12 months.

  • Editorial Comment
    In a well-constructed scientific study, the authors describe and analyze a technique to address female stress urinary incontinence utilizing radiofrequency energy to denature collagen in multiple microscopic sites causing a change in the compliance of the tissue. This anatomic change will theoretically reduce the inappropriate opening of the bladder neck and proximal urethra with stress maneuvers much in the manner of the sub urethral support of a sling. The technique utilizes less energy than that used by radiofrequency tissue ablation for renal masses and/or gynecological conditions. During the study, the authors used the Incontinence Quality of Life questionnaire (I-QOL) to grade the patient’s incontinence (as opposed to pad weight test) as well as urodynamics including leak point pressure determination. These metrics did make it a little challenging to note if any of the patients were absolutely dry post procedure. Nevertheless, treated patients were able to exhibit a statistically significant increase in leak point pressure at the 12-month follow-up period as opposed to those patients who underwent a sham treatment thus indicating a measure of efficacy (1). This study does speak volumes to the effect of placebo therapy for at the 12-month period almost 50% of both treated and sham groups had a > 10 point I-QOL score improvement. The authors do clearly hi-light the safety and tolerability of this procedure and denote that radiofrequency micro remodeling clearly responds to the incontinent patients who will settle for improvement as opposed to cure in a trade-off for having a minimally invasive procedure. Similar patient desires with regards to injectable therapy have been noted in this journal (2).

References
1. Petrou SP, Broderick GA: Valsalva leak-point pressure changes after successful and failed suburethral sling. Int Urogynecol J Pelvic Floor Dysfunct. 2002; 13: 299-302.
2. Petrou SP, Lisson SW, Crook JE, Lightner DJ: An exploration into patient preference for injectable therapy over surgery in the treatment of female urinary incontinence. Int Braz J Urol. 2006; 32: 578-82.

Dr. Steven P. Petrou
Associate Professor of Urology
Chief of Surgery, St. Luke’s Hospital
Associate Dean, Mayo School of Graduate Medical Education
Jacksonville, Florida, USA